Kalpana M. Merchant, Ph.D. (2020)

Kalpana M. Merchant, Ph.D., is president and chief scientific officer at TransThera Consulting Co., where she has developed scientific and business strategies for integrating translational science into drug discovery and development for neuroscience, metabolic disorders and oncology. Merchant’s extensive knowledge of psychiatric (schizophrenia, major depression, anxiety, attention deficit hyperactivity disorder) and neurodegenerative (Alzheimer’s disease and Parkinson’s disease) disorders has contributed to the discovery and validation of multiple new targets using genomic and genetic technologies and to the clinical development of therapeutic agents directed toward those targets. Merchant previously served as chief scientific officer, Tailored Therapeutics (neuroscience), and chief scientific officer, Translational Sciences and Technologies, at Eli Lilly and Company and currently serves as an advisor and consultant to the Michael J. Fox Foundation for Parkinson’s Research, Third Rock Ventures, angel investors, and several small biotechnology startups. Merchant holds adjunct faculty positions at Northwestern University Feinberg School of Medicine and Purdue University School of Science at Indiana University–Purdue University Indianapolis. She contributes to the broader scientific community through service to the Wellcome Trust, NIH/National Academy of Medicine workshops and advisory panels, the American College of Neuropsychopharmacology, the New York Academy of Sciences, the American Association for the Advancement of Science and the Dystonia Medical Research Foundation. Merchant received her Ph.D. in neuropharmacology from the University of Utah.